MedTrace Logo

Effects of Early Yakson Touch and Kinesthetic Stimulation on the Development of High Risk Neonates

NCT02815904 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2018-08-16

No results posted yet for this study

Summary

The role of physiotherapy interventions in treatment of high risk infants has not been established even after a number of studies. The high risk infants are prone to developmental delays and early intervention is most effective for them owing to the plasticity of brain in early infancy. Yakson is one among the most effective and safe methods of tactile stimulation for preterm neonates. Tactile and kinesthetic stimulation techniques have been proved to be effective but there is no standardized protocol. The present study will try to investigate the efficacy of Yakson touch in combination with kinesthetic stimulation on the development of high risk neonates against conventional handling which will include developmental positioning and Kangaroo mother care.

Conditions

  • Preterm Infants
  • Infant, Low Birth Weight

Interventions

OTHER

Yakson touch

Yakson is a Korean therapeutic touch given to neonates and infants by caressing their abdomen with one hand while the other hand is placed on the back of the neonate\\infant to relieve their pain or to calm them down.

OTHER

Conventional handling

Positioning of preterm infants for optimal physiological development

OTHER

Kinesthetic stimulation

For kinesthetic stimulation, all the limbs were given six passive flexion and extension movements

OTHER

Kangaroo Mother Care

Providing skin to skin human touch

Sponsors & Collaborators

  • Maharishi Markendeswar University (Deemed to be University)

    collaborator OTHER

  • Asir John Samuel

    lead OTHER

Principal Investigators

  • Preeti Parashar, BPT · Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation, Maharishi Markandeshwar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
2 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-04-30
Completion
2017-05-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02815904 on ClinicalTrials.gov